This CME-accredited activity, 2025 Seattle Cellular Therapy Summit, features leading experts who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of cellular

The Summit on Cancer Health Disparities 2025 (SCHD25) is a premier annual event focused on addressing cancer health disparities. The conference serves to bridge research and practice, offering practical strategies to improve cancer care delivery and outcomes.

This CME-accredited activity, Chicago Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice, features leading experts in hematologic malignancies and cellular therapies who will provide a compr

This CME-accredited activity, 2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility, features leading experts who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid

This annual oncology conference, The Summit on Cancer Health Disparities (SCHD24), is one of the largest gatherings of cancer care professionals interested in cancer health disparities with a focus on achieving health equity.

This accredited continuing education activity “Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes” is recorded from the live conference held from 8/04/2023 to 8/05/2023.

This CME-accredited activity, “Seattle Cellular Therapy Summit (SCTS): Patient-Centered Approach to Improve Outcomes,” features leading experts in hematologic malignancies and cellular therapies who will provide a comprehensive overview of current and emerging strategies f

This annual oncology conference, 2023 Summit on Cancer Health Disparities: Reframing and Addressing Barriers to Adoption of Precision Oncology (SCHD23), will feature lectures, panel discussions and debates among leaders across the spectrum of cancer care delivery.